{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:05:37Z","timestamp":1785225937282,"version":"3.55.0"},"reference-count":109,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Nucl Med Mol Imaging"],"DOI":"10.62347\/nanx3492","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T03:58:34Z","timestamp":1720411114000},"page":"161-174","source":"Crossref","is-referenced-by-count":7,"title":["Current uses and understanding of PET imaging in cardiac sarcoidosis"],"prefix":"10.62347","volume":"14","author":[{"given":"Alekhya","family":"Madiraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1172-2-46","article-title":"Sarcoidosis","volume":"2","author":"Nunes","year":"2007","unstructured":"Nunes H, Bouvry D, Soler P and Valeyre D. Sarcoidosis. Orphanet J Rare Dis 2007; 2: 46.","journal-title":"Orphanet J Rare Dis"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2967\/jnumed.112.115121","article-title":"Advanced imaging of cardiac sarcoidosis","volume":"55","author":"Schatka","year":"2014","unstructured":"Schatka I and Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med 2014; 55: 99-106.","journal-title":"J Nucl Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","unstructured":"Tavora F, Cresswell N, Li L, Ripple M, Solomon C and Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009; 104: 571-577.","journal-title":"Am J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"JP 3rd","year":"2014","unstructured":"Lynch JP 3rd, Hwang J, Bradfield J, Fishbein M, Shivkumar K and Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med 2014; 35: 372-390.","journal-title":"Semin Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Martusewicz-Boros MM, Boros PW, Wiatr E, Kempisty A, Piotrowska-Kownacka D and Roszkowski-&#x15A;li&#x17C; K. Cardiac sarcoidosis: is it more common in men? Lung 2016; 194: 61-66.","DOI":"10.1007\/s00408-015-9805-8"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/jamaophthalmol.2017.5466","article-title":"Distinguishing uveitis secondary to sarcoidosis from idiopathic disease: cardiac implications","volume":"136","author":"Han","year":"2018","unstructured":"Han YS, Rivera-Grana E, Salek S and Rosenbaum JT. Distinguishing uveitis secondary to sarcoidosis from idiopathic disease: cardiac implications. JAMA Ophthalmol 2018; 136: 109-115.","journal-title":"JAMA Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Durugu S, Gonuguntla K, Patil S, Rojulpote C, Vyata V, Karambelkar P, Narayanareddy P, Vuthaluru K and Bhattaru A. Gender differences in rates of arrhythmias, cardiac implantable electronic devices, and diagnostic modalities among sarcoidosis patients. Cureus 2020; 12: e7667.","DOI":"10.7759\/cureus.7667"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rojulpote C, Gonuguntla K, Patil S, Karambelkar P, Buch T, Bhattaru A, Vuthaluru K, Perosevic N and Bravo PE. Abstract 15038: gender differences amongst Caucasians and African Americans in rates of arrhythmias, implantable cardiac devices, and in-hospital mortality in sarcoidosis patients with cardiomyopathy. Circulation 2020; 142: A15038.","DOI":"10.1161\/circ.142.suppl_3.15038"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"KJ","year":"1978","unstructured":"Silverman KJ, Hutchins GM and Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietil&#xE4;-Effati P, Utrianen S and Kupari M. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015; 131: 624-632.","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","unstructured":"Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, Homma AH, Mikami R, Hongo O, Hiraga Y and Yamamoto M. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976; 278: 455-469.","journal-title":"Ann N Y Acad Sci"},{"key":"ref11","unstructured":"Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A and Noguchi TI. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994; 11: 26-31."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"RP","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLENNAN G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL and Cherniak R; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-1889.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto","year":"2008","unstructured":"Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M and Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31: 372-379.","journal-title":"Eur Respir J"},{"key":"ref14","unstructured":"Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS and Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther 2016; 6: 50-63."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1253\/jcj.44.249","article-title":"Sarcoidosis","volume":"44","author":"Sekiguchi","year":"1980","unstructured":"Sekiguchi M, Numao Y, Imai M, Furuie T and Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 1980; 44: 249-263.","journal-title":"Jpn Circ J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"LT","year":"2007","unstructured":"Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J and Virmani R; American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007; 116: 2216-2233.","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P and Soejima K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11: 1305-1323.","journal-title":"Heart Rhythm"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy","volume":"150","author":"Ardehali","year":"2005","unstructured":"Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL and Kasper EK. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 2005; 150: 459-463.","journal-title":"Am Heart J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","unstructured":"Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T and Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299-302.","journal-title":"Am Heart J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","unstructured":"Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivist&#xF6; SM and Kupari M. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270: 461-468.","journal-title":"J Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Oe Y, Ishibashi-Ueda H, Matsuyama TA, Kuo YH, Nagai T, Ikeda Y, Ohta-Ogo K, Noguchi T and Anzai T. Lymph vessel proliferation on cardiac biopsy may help in the diagnosis of cardiac sarcoidosis. J Am Heart Assoc 2019; 8: e010967.","DOI":"10.1161\/JAHA.118.010967"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1378\/chest.107.2.330","article-title":"Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis","volume":"107","author":"Okayama","year":"1995","unstructured":"Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K and Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995; 107: 330-334.","journal-title":"Chest"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1540-8167.2008.01417.x","article-title":"The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities","volume":"20","author":"Soejima","year":"2009","unstructured":"Soejima K and Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009; 20: 578-583.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s11886-013-0370-6","article-title":"18F-FDG PET\/CT for the assessment of myocardial sarcoidosis","volume":"15","author":"Skali","year":"2013","unstructured":"Skali H, Schulman AR and Dorbala S. 18F-FDG PET\/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep 2013; 15: 352.","journal-title":"Curr Cardiol Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.110.952184","article-title":"Images in cardiovascular medicine: imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case","volume":"122","author":"Koiwa","year":"2010","unstructured":"Koiwa H, Tsujino I, Ohira H, Yoshinaga K, Otsuka N and Nishimura M. Images in cardiovascular medicine: imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case. Circulation 2010; 122: 535-536.","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/hrt.2005.073742","article-title":"Cardiac sarcoidosis in a 60 year old woman","volume":"92","author":"JP","year":"2006","unstructured":"Smedema JP, Reenaers V and Geukens R. Images in cardiology. Cardiac sarcoidosis in a 60 year old woman. Heart 2006; 92: 688.","journal-title":"Heart"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"897956","DOI":"10.1155\/2014\/897956","article-title":"Assessment of cardiac sarcoidosis with advanced imaging modalities","volume":"2014","author":"Orii","year":"2014","unstructured":"Orii M, Imanishi T and Akasaka T. Assessment of cardiac sarcoidosis with advanced imaging modalities. Biomed Res Int 2014; 2014: 897956.","journal-title":"Biomed Res Int"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jacc.2012.09.074","article-title":"Cardiac sarcoidosis","volume":"61","author":"Kadosh","year":"2013","unstructured":"Kadosh B, Steele J, Gulkarov I and Mamkin I. Cardiac sarcoidosis. J Am Coll Cardiol 2013; 61: 1548.","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: a comprehensive review","volume":"7","author":"Sekhri","year":"2011","unstructured":"Sekhri V, Sanal S, DeLorenzo LJ, Aronow WS and Maguire GP. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci 2011; 7: 546-554.","journal-title":"Arch Med Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","unstructured":"Nery PB, Mc Ardle BA, Redpath CJ, Leung E, Lemery R, Dekemp R, Yang J, Keren A, Beanlands RS and Birnie DH. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 2014; 37: 364-374.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ccep.2015.03.006","article-title":"Cardiac sarcoidosis and consequent arrhythmias","volume":"7","author":"Zipse","year":"2015","unstructured":"Zipse MM and Sauer WH. Cardiac sarcoidosis and consequent arrhythmias. Card Electrophysiol Clin 2015; 7: 235-249.","journal-title":"Card Electrophysiol Clin"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Ayyala US, Nair AP and Padilla ML. Cardiac sarcoidosis. Clin Chest Med 2008; 29: 493-508, ix.","DOI":"10.1016\/j.ccm.2008.03.005"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1378\/chest.11-3214","article-title":"Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications","volume":"143","author":"Viles-Gonzalez","year":"2013","unstructured":"Viles-Gonzalez JF, Pastori L, Fischer A, Wisnivesky JP, Goldman MG and Mehta D. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest 2013; 143: 1085-1090.","journal-title":"Chest"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/clc.4960270409","article-title":"Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome","volume":"27","author":"Furushima","year":"2004","unstructured":"Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T and Aizawa Y. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 2004; 27: 217-222.","journal-title":"Clin Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","unstructured":"Koplan BA, Soejima K, Baughman K, Epstein LM and Stevenson WG. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006; 3: 924-929.","journal-title":"Heart Rhythm"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","unstructured":"Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, Gulenchyn KY, deKemp RA, DaSilva J, Birnie D, Wells GA and Beanlands RS. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012; 53: 241-248.","journal-title":"J Nucl Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytz188","article-title":"The use of serial cardiac 18F-fluorodeoxyglucose-positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and review","volume":"3","author":"Kersey","year":"2019","unstructured":"Kersey CB, Flaherty KR, Goldenthal IL, Bokhari S and Biviano AB. The use of serial cardiac 18F-fluorodeoxyglucose-positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and review. Eur Heart J Case Rep 2019; 3: 1-7.","journal-title":"Eur Heart J Case Rep"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ehf2.12472","article-title":"Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography","volume":"6","author":"Maeda","year":"2019","unstructured":"Maeda D, Kanzaki Y, Fujita S, Inuyama M, Takashima S, Miyamura M, Terasaki F and Hoshiga M. Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography. ESC Heart Fail 2019; 6: 889-893.","journal-title":"ESC Heart Fail"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12350-017-0940-x","article-title":"18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: female sex and history of atrioventricular block increase the prevalence of positive PET findings","volume":"26","author":"Tuominen","year":"2019","unstructured":"Tuominen H, Haarala A, Tikkakoski A, Korkola P, K&#xE4;h&#xF6;nen M, Nikus K and Sipil&#xE4; K. 18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: female sex and history of atrioventricular block increase the prevalence of positive PET findings. J Nucl Cardiol 2019; 26: 394-400.","journal-title":"J Nucl Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s12350-018-01541-7","article-title":"18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis","volume":"27","author":"Omote","year":"2020","unstructured":"Omote K, Naya M, Koyanagawa K, Aikawa T, Manabe O, Nagai T, Kamiya K, Kato Y, Komoriyama H, Kuzume M, Tamaki N and Anzai T. 18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis. J Nucl Cardiol 2020; 27: 2135-2143.","journal-title":"J Nucl Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","unstructured":"Greulich S, Deluigi CC, Gloekler S, Wahl A, Z&#xFC;rn C, Kramer U, Nothnagel D, B&#xFC;ltel H, Schumm J, Gr&#xFC;n S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O and Mahrholdt H. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6: 501-511.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref42","unstructured":"Rojulpote C, Bhattaru A, Karambelkar P, Rodriguez J and Bravo P. Effect of myocardial inflammation suppression and prednisone therapy on outcomes in patients with suspected cardiac sarcoidosis. J Nucl Med 2021; 62: 1656."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/europace\/euu052","article-title":"Correlation of inflammation due to cardiac sarcoidosis by positron emission tomography-computed tomography imaging and endocardial voltage mapping in a patient with recurrent ventricular tachycardia","volume":"16","author":"Siddiqi","year":"2014","unstructured":"Siddiqi FK, Paz YE, Olesnicky L, Bokhari S and Cheung JW. Correlation of inflammation due to cardiac sarcoidosis by positron emission tomography-computed tomography imaging and endocardial voltage mapping in a patient with recurrent ventricular tachycardia. Europace 2014; 16: 907.","journal-title":"Europace"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","unstructured":"Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S and Di Carli MF. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014; 63: 329-336.","journal-title":"J Am Coll Cardiol"},{"key":"ref45","unstructured":"Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T and Kurabayashi M. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004; 45: 1989-1998."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.nuclcard.2008.01.006","article-title":"Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator","volume":"15","author":"Casset-Senon","year":"2008","unstructured":"Casset-Senon D, Philippe L, Renard JP and Cosnay P. Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator. J Nucl Cardiol 2008; 15: 282-285.","journal-title":"J Nucl Cardiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","unstructured":"Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, Machac J and Teirstein A. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008; 133: 1426-1435.","journal-title":"Chest"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","unstructured":"Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC and Cooper JM. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012; 9: 884-891.","journal-title":"Heart Rhythm"},{"key":"ref49","unstructured":"Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K and Yoshikawa J. Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET. J Nucl Med 2003; 44: 1030-1036."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1007\/s00259-014-2826-3","article-title":"FDG PET\/CT methodology for evaluation of treatment response in lymphoma: from &#x201C;graded visual analysis&#x201D; and &#x201C;semiquantitative SUVmax&#x201D; to global disease burden assessment","volume":"41","author":"Basu","year":"2014","unstructured":"Basu S, Zaidi H, Salavati A, Hess S, Carlsen PF and Alavi A. FDG PET\/CT methodology for evaluation of treatment response in lymphoma: from &#x201C;graded visual analysis&#x201D; and &#x201C;semiquantitative SUVmax&#x201D; to global disease burden assessment. Eur J Nucl Med Mol Imaging 2014; 41: 2158-2160.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"PI","year":"2017","unstructured":"Lee PI, Cheng G and Alavi A. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. J Nucl Cardiol 2017; 24: 19-28.","journal-title":"J Nucl Cardiol"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"H&#xF8;ilund-Carlsen PF, Edenbrandt L and Alavi A. Global disease score (GDS) is the name of the game! Eur J Nucl Med Mol Imaging 2019; 46: 1768-1772.","DOI":"10.1007\/s00259-019-04383-8"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00259-020-04697-y","article-title":"Potential of PET\/CT in assessing dementias with emphasis on cerebrovascular disorders","volume":"47","author":"Borja","year":"2020","unstructured":"Borja AJ, Hancin EC, Zhang V, Revheim ME and Alavi A. Potential of PET\/CT in assessing dementias with emphasis on cerebrovascular disorders. Eur J Nucl Med Mol Imaging 2020; 47: 2493-2498.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Bhattaru A, Raynor WY, Patil S, Rojulpote C, Bravo PE, Gonuguntla K, Karambelkar P, Vuthaluru K, Seraj SM, Zhang V, Werner T, Baker JF and Alavi A. Association of serum leptin and abdominal aortic inflammation in rheumatoid arthritis. Circulation 2020; 142: A14521.","DOI":"10.1161\/circ.142.suppl_3.14521"},{"key":"ref55","unstructured":"Bhattaru A, Rojulpote C, Gonuguntla K, Patil S, Karambelkar P, Vuthaluru K, Zhang V, Borja AJ, Raynor WY, Werner TJ, Gerke O, H&#xF8;ilund-Carlsen PF and Alavi A. An understanding of the atherosclerotic molecular calcific heterogeneity between coronary, upper limb, abdominal, and lower extremity arteries as assessed by NaF PET\/CT. Am J Nucl Med Mol Imaging 2021; 11: 40-45."},{"key":"ref56","unstructured":"Rojulpote C, Patil S, Gonuguntla K, Karambelkar P, Bravo PE, Seraj SM, Asadollahi S, Raynor WY, Bhattaru A, Borja AJ, Zhang V, Werner TJ, Gerke O, H&#xF8;ilund-Carlsen PF and Alavi A. NaF-PET\/CT global assessment in detecting and quantifying subclinical cardiac atherosclerosis and its association with blood pressure in non-dyslipidemic individuals. Am J Cardiovasc Dis 2020; 10: 101-107."},{"key":"ref57","unstructured":"Patil S, Rojulpote C, Gonuguntla K, Karambelkar P, Bhattaru A, Raynor WY, Borja AJ, Vuthaluru K, Zhang V, Werner TJ, Gerke O, H&#xF8;ilund-Carlsen PF and Alavi A. Association of triglyceride to high density lipoprotein ratio with global cardiac microcalcification to evaluate subclinical coronary atherosclerosis in non-diabetic individuals. Am J Cardiovasc Dis 2020; 10: 241-246."},{"key":"ref58","unstructured":"Borja AJ, Bhattaru A, Rojulpote C, Hancin EC, Detchou DK, Patil S, Gonuguntla K, Karambelkar P, Chinta S, Vuthaluru K, Werner TJ, Gerke O, H&#xF8;ilund-Carlsen PF and Alavi A. Association between atherosclerotic cardiovascular disease risk score estimated by pooled cohort equation and coronary plaque burden as assessed by NaF-PET\/CT. Am J Nucl Med Mol Imaging 2020; 10: 312-318."},{"key":"ref59","unstructured":"Gonuguntla K, Rojulpote C, Patil S, Bhattaru A, Karambelkar P, Vuthaluru K, Raynor WY, Borja AJ, Zhang V, Werner TJ, Gerke O, H&#xF8;ilund-Carlsen PF and Alavi A. Utilization of NaF-PET\/CT in assessing global cardiovascular calcification using CHADS2 and CHADS2-VASc scoring systems in high risk individuals for cardiovascular disease. Am J Nucl Med Mol Imaging 2020; 10: 293-300."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2967\/jnumed.117.199778","article-title":"Predictive value of 18F-FDG PET in patients with advanced medullary thyroid carcinoma treated with vandetanib","volume":"59","author":"RA","year":"2018","unstructured":"Werner RA, Schmid JS, Higuchi T, Javadi MS, Rowe SP, M&#xE4;rkl B, Aulmann C, Fassnacht M, Kroiss M, Reiners C, Buck AK, Kreissl MC and Lapa C. Predictive value of 18F-FDG PET in patients with advanced medullary thyroid carcinoma treated with vandetanib. J Nucl Med 2018; 59: 756-761.","journal-title":"J Nucl Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13550-018-0397-1","article-title":"Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study","volume":"8","author":"Stevenson","year":"2018","unstructured":"Stevenson MG, Been LB, Hoekstra HJ, Suurmeijer AJH, Boellaard R and Brouwers AH. Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study. EJNMMI Res 2018; 8: 42.","journal-title":"EJNMMI Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","unstructured":"Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, Michaud GF, Tedrow UB and Stevenson WG. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 2015; 8: 87-93.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.hrthm.2019.10.017","article-title":"Direct and indirect mapping of intramural space in ventricular tachycardia","volume":"17","author":"Bhaskaran","year":"2020","unstructured":"Bhaskaran A, Nayyar S, Porta-S&#xE1;nchez A, Jons C, Mass&#xE9; S, Magtibay K, Aukhojee P, Ha A, Bokhari M, Tung R, Downar E and Nanthakumar K. Direct and indirect mapping of intramural space in ventricular tachycardia. Heart Rhythm 2020; 17: 439-446.","journal-title":"Heart Rhythm"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Tokuda M, Tedrow UB, Inada K, Reichlin T, Michaud GF, John RM, Epstein LM and Stevenson WG. Direct comparison of adjacent endocardial and epicardial electrograms: implications for substrate mapping. J Am Heart Assoc 2013; 2: e000215.","DOI":"10.1161\/JAHA.113.000215"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/jce.13282","article-title":"The effect of activation rate on left atrial bipolar voltage in patients with paroxysmal atrial fibrillation","volume":"28","author":"SE","year":"2017","unstructured":"Williams SE, Linton N, O&#x2019;Neill L, Harrison J, Whitaker J, Mukherjee R, Rinaldi CA, Gill J, Niederer S, Wright M and O&#x2019;Neill M. The effect of activation rate on left atrial bipolar voltage in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2017; 28: 1028-1036.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.hrthm.2010.09.088","article-title":"Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"8","author":"Polin","year":"2011","unstructured":"Polin GM, Haqqani H, Tzou W, Hutchinson MD, Garcia FC, Callans DJ, Zado ES and Marchlinski FE. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Heart Rhythm 2011; 8: 76-83.","journal-title":"Heart Rhythm"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Mathew S, Saguner AM, Schenker N, Kaiser L, Zhang P, Yashuiro Y, Lemes C, Fink T, Maurer T, Santoro F, Wohlmuth P, Rei&#xDF;mann B, Heeger CH, Tilz R, Wissner E, Rillig A, Metzner A, Kuck KH and Ouyang F. Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a sequential approach. J Am Heart Assoc 2019; 8: e010365.","DOI":"10.1161\/JAHA.118.010365"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","article-title":"Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Dalal","year":"2007","unstructured":"Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE and Calkins H. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy. J Am Coll Cardiol 2007; 50: 432-440.","journal-title":"J Am Coll Cardiol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Philips","year":"2012","unstructured":"Philips B, Madhavan S, James C, Tichnell C, Murray B, Dalal D, Bhonsale A, Nazarian S, Judge DP, Russell SD, Abraham T, Calkins H and Tandri H. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Circ Arrhythm Electrophysiol 2012; 5: 499-505.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Muser D, Santangeli P, Pathak RK, Castro SA, Liang JJ, Magnani S, Hayashi T, Garcia FC, Hutchinson MD, Supple GE, Frankel DS, Riley MP, Lin D, Schaller RD, Desjardins B, Dixit S, Callans DJ, Zado ES and Marchlinski FE. Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis. Circ Arrhythm Electrophysiol 2016; 9: e004333.","DOI":"10.1161\/CIRCEP.116.004333"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1540-8167.2009.01563.x","article-title":"Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter euro-VT-study","volume":"21","author":"Tanner","year":"2010","unstructured":"Tanner H, Hindricks G, Volkmer M, Furniss S, K&#xFC;hlkamp V, Lacroix D, De Chillou C, Almendral J, Caponi D, Kuck KH and Kottkamp H. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter euro-VT-study. J Cardiovasc Electrophysiol 2010; 21: 47-53.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou","year":"2018","unstructured":"Papageorgiou N, Provid&#xEA;ncia R, Bronis K, Dechering DG, Srinivasan N, Eckardt L and Lambiase PD. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review. Europace 2018; 20: 682-691.","journal-title":"Europace"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","unstructured":"Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, Yu R, Vangala S, Tseng CH, Choi EK, Khurshid S, Patel M, Mathuria N, Nakahara S, Tzou WS, Sauer WH, Vakil K, Tedrow U, Burkhardt JD, Tholakanahalli VN, Saliaris A, Dickfeld T, Weiss JP, Bunch TJ, Reddy M, Kanmanthareddy A, Callans DJ, Lakkireddy D, Natale A, Marchlinski F, Stevenson WG, Della Bella P and Shivkumar K. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study. Heart Rhythm 2015; 12: 1997-2007.","journal-title":"Heart Rhythm"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Birnie DH, Kandolin R, Nery PB and Kupari M. Cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J 2017; 38: 2663-2670.","DOI":"10.1093\/eurheartj\/ehw328"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10840-015-9978-3","article-title":"Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator","volume":"43","author":"Kron","year":"2015","unstructured":"Kron J, Sauer W, Mueller G, Schuller J, Bogun F, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA and Crawford T. Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator. J Interv Card Electrophysiol 2015; 43: 55-64.","journal-title":"J Interv Card Electrophysiol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","unstructured":"Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, Kitakaze M, Tomoike H and Miyatake K. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-146.","journal-title":"Am J Cardiol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","article-title":"Cardiac sarcoidosis: a retrospective study of 41 cases","volume":"83","author":"Chapelon-Abric C","year":"2004","unstructured":"Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DLT, de Gennes C, Papo T, Bl&#xE9;try O, Godeau P and Piette JC. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004; 83: 315-334.","journal-title":"Medicine (Baltimore)"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cjca.2013.02.004","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","unstructured":"Sadek MM, Yung D, Birnie DH, Beanlands RS and Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol 2013; 29: 1034-1041.","journal-title":"Can J Cardiol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","unstructured":"Nagai S, Yokomatsu T, Tanizawa K, Ikezoe K, Handa T, Ito Y, Ogino S and Izumi T. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med 2014; 53: 427-433.","journal-title":"Intern Med"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1183\/09031936.06.00105805","article-title":"Corticosteroid treatment in sarcoidosis","volume":"28","author":"Grutters","year":"2006","unstructured":"Grutters JC and van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J 2006; 28: 627-636.","journal-title":"Eur Respir J"},{"key":"ref81","unstructured":"Hiramitsu S, Morimoto S, Uemura A, Kato Y, Kimura K, Ohtsuki M, Kato S, Sugiura A, Miyagishima K, Hishida H, Sugisaki K and Tsuda T. National survey on status of steroid therapy for cardiac sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 210-213."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1573403X14666180716164740","article-title":"Subcutaneous implantable cardioverter defibrillators: an overview of implantation techniques and clinical outcomes","volume":"15","author":"Al-Ghamdi","year":"2019","unstructured":"Al-Ghamdi B. Subcutaneous implantable cardioverter defibrillators: an overview of implantation techniques and clinical outcomes. Curr Cardiol Rev 2019; 15: 38-48.","journal-title":"Curr Cardiol Rev"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Almehmadi F, Porta-S&#xE1;nchez A, Ha ACT, Fischer HD, Wang X, Austin PC, Lee DS and Nanthakumar K. Mortality implications of appropriate implantable cardioverter defibrillator therapy in secondary prevention patients: contrasting mortality in primary prevention patients from a prospective population-based registry. J Am Heart Assoc 2017; 6: e006220.","DOI":"10.1161\/JAHA.117.006220"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11886-014-0514-3","article-title":"Cardiac sarcoidosis","volume":"16","author":"Zipse","year":"2014","unstructured":"Zipse MM and Sauer WH. Cardiac sarcoidosis. Curr Cardiol Rep 2014; 16: 514.","journal-title":"Curr Cardiol Rep"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/postgradmedj-2014-133219","article-title":"Cardiac sarcoidosis: diagnosis and management","volume":"91","author":"Dubrey","year":"2015","unstructured":"Dubrey SW, Sharma R, Underwood R and Mittal T. Cardiac sarcoidosis: diagnosis and management. Postgrad Med J 2015; 91: 384-394.","journal-title":"Postgrad Med J"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","unstructured":"Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, Sweiss NJ, Nguyen DT, Aleong RG, Varosy PD, Weinberger HD and Sauer WH. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2012; 23: 925-929.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Nadel J, Lancefield T, Voskoboinik A and Taylor AJ. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Eur Heart J Cardiovasc Imaging 2015; 16: 634-641.","DOI":"10.1093\/ehjci\/jeu294"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1378\/chest.106.5.1603","article-title":"Prophylaxis in cardiac sarcoidosis","volume":"106","author":"Paz","year":"1994","unstructured":"Paz HL, McCormick DJ, Kutalek SP and Patchefsky A. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest 1994; 106: 1603-1607.","journal-title":"Chest"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"243","DOI":"10.11604\/pamj.2015.21.243.6124","article-title":"Sarcoidosis with heart involvement: a rare association of terrible prognosis, a report of two cases","volume":"21","author":"Kefi","year":"2015","unstructured":"Kefi A, Ben Abdelhafidh N, Sayhi S, Abid R, Ajili F, Laabidi J and Othmani S. Sarcoidosis with heart involvement: a rare association of terrible prognosis, a report of two cases. Pan Afr Med J 2015; 21: 243.","journal-title":"Pan Afr Med J"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","article-title":"Recurrence of cardiac sarcoidosis in a heart transplant recipient","volume":"24","author":"Yager","year":"2005","unstructured":"Yager JE, Hernandez AF, Steenbergen C, Persing B, Russell SD, Milano C and Felker GM. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant 2005; 24: 1988-1990.","journal-title":"J Heart Lung Transplant"},{"key":"ref91","unstructured":"Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM and Hosenpud JD. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992; 11: 367-369."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.healun.2007.05.006","article-title":"Outcome of heart transplantation in patients with sarcoid cardiomyopathy","volume":"26","author":"AR","year":"2007","unstructured":"Zaidi AR, Zaidi A and Vaitkus PT. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 2007; 26: 714-717.","journal-title":"J Heart Lung Transplant"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Ratib O and Nkoulou R. Potential applications of PET\/MR imaging in cardiology. J Nucl Med 2014; 55: 40S-46S.","DOI":"10.2967\/jnumed.113.129262"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12410-013-9213-5","article-title":"State of the art in cardiac hybrid technology: PET\/MR","volume":"6","author":"Nappi","year":"2013","unstructured":"Nappi C and El Fakhri G. State of the art in cardiac hybrid technology: PET\/MR. Curr Cardiovasc Imaging Rep 2013; 6: 338-345.","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","unstructured":"Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM and Elliott PM. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 2018; 19: 757-767.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","unstructured":"Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA and Kovacic JC. Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. JACC Cardiovasc Imaging 2018; 11: 94-107.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5152\/dir.2014.14008","article-title":"Clinical applications of PET\/MRI: current status and future perspectives","volume":"20","author":"Nensa","year":"2014","unstructured":"Nensa F, Beiderwellen K, Heusch P and Wetter A. Clinical applications of PET\/MRI: current status and future perspectives. Diagn Interv Radiol 2014; 20: 438-447.","journal-title":"Diagn Interv Radiol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s12350-018-01578-8","article-title":"Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis","volume":"27","author":"Wisenberg","year":"2020","unstructured":"Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B and Prato FS. Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis. J Nucl Cardiol 2020; 27: 2118-2129.","journal-title":"J Nucl Cardiol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/eurheartj\/eht335","article-title":"Utility of multimodal cardiac imaging with PET\/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment","volume":"35","author":"Schneider","year":"2014","unstructured":"Schneider S, Batrice A, Rischpler C, Eiber M, Ibrahim T and Nekolla SG. Utility of multimodal cardiac imaging with PET\/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment. Eur Heart J 2014; 35: 312.","journal-title":"Eur Heart J"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"O&#x2019;Meara C, Menezes LJ, White SK, Wicks E and Elliott P. Inital experience of imaging cardiac sarcoidosis using hybrid PET-MR - a technologist&#x2019;s case study. J Cardiovasc Magn Reson 2013; 15 Suppl 1: T1.","DOI":"10.1186\/1532-429X-15-S1-T1"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"White JA, Rajchl M, Butler J, Thompson RT, Prato FS and Wisenberg G. Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease. Circulation 2013; 127: e639-41.","DOI":"10.1161\/CIRCULATIONAHA.112.001217"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4103\/wjnm.WJNM_71_17","article-title":"Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging and positron emission tomography\/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1","volume":"17","author":"Raad","year":"2018","unstructured":"Raad RA, Lala S, Allen JC, Babb J, Mitchell CW, Franceschi AM, Yohay K and Friedman KP. Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging and positron emission tomography\/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1. World J Nucl Med 2018; 17: 241-248.","journal-title":"World J Nucl Med"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/ehjci\/jeac031","article-title":"Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PET","volume":"23","author":"Selvaraj","year":"2022","unstructured":"Selvaraj S, Seidelmann SB, Soni M, Bhattaru A, Margulies KB, Shah SH, Dugyala S, Qian C, Pryma DA, Arany Z, Kelly DP, Chirinos JA and Bravo PE. Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PET. Eur Heart J Cardiovasc Imaging 2022; 23: 1690-1697.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref104","unstructured":"Vidula M, Selvaraj S, Rojulpote C, Bhattaru A, Hansbury M, Schubert E, Clancy C, Rossman M, Goldberg L, Farwell M, Pryma D and Bravo P. Relationship of beta-hydroxybutyrate levels and ketosis duration with diagnostic FDG-PET studies performed for the evaluation of active cardiac sarcoidosis. J Nucl Med 2023."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.jcmg.2022.05.015","article-title":"Effect of immunosuppressive therapy and biopsy status in monitoring therapy response in suspected cardiac sarcoidosis","volume":"15","author":"Rojulpote","year":"2022","unstructured":"Rojulpote C, Bhattaru A, Jean C, Adams SL, Patel V, Vidula MK, Selvaraj S, Dubroff J, Peyster E, Clancy CB, Patterson K, Marchlinski FE, Rossman M, Goldberg L and Bravo PE. Effect of immunosuppressive therapy and biopsy status in monitoring therapy response in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2022; 15: 1944-1955.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref106","unstructured":"Asadollahi S, Rojulpote C, Bhattaru A, Patil S, Gonuguntla K, Karambelkar P, Borja AJ, Vuthaluru K, Seraj SM, Zhang V, Werner TJ, Gerke O, H&#xF8;ilund-Carlsen PF and Alavi A. Comparison of atherosclerotic burden in non-lower extremity arteries in patients with and without peripheral artery disease using 18F-NaF-PET\/CT imaging. Am J Nucl Med Mol Imaging 2020; 10: 272-278."},{"key":"ref107","unstructured":"Kaghazchi F, Borja AJ, Hancin EC, Bhattaru A, Detchou DKE, Seraj SM, Rojulpote C, Hess S, Nardo L, Gabriel PE, Damrauer SM, Werner TJ, Alavi A and Revheim ME. Venous thromboembolism detected by FDG-PET\/CT in cancer patients: a common, yet life-threatening observation. Am J Nucl Med Mol Imaging 2021; 11: 99-106."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/MNM.0000000000001349","article-title":"Global brain glucose uptake on 18F-FDG-PET\/CT is influenced by chronic cardiovascular risk","volume":"42","author":"AJ","year":"2021","unstructured":"Borja AJ, Hancin EC, Zhang V, Koa B, Bhattaru A, Rojulpote C, Detchou DK, Aly M, Kaghazchi F, Gerke O, Patil S, Gonuguntla K, Werner TJ, Revheim ME, H&#xF8;ilund-Carlsen PF and Alavi A. Global brain glucose uptake on 18F-FDG-PET\/CT is influenced by chronic cardiovascular risk. Nucl Med Commun 2021; 42: 444-450.","journal-title":"Nucl Med Commun"}],"container-title":["American Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajnmmi\/14\/3\/ajnmmi0154433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:54:05Z","timestamp":1766022845000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajnmmi\/14\/3\/ajnmmi0154433.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":109,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/nanx3492","relation":{},"ISSN":["2160-8407"],"issn-type":[{"value":"2160-8407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}